Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?

被引：0
|
作者：
Morgan H. James
Jennifer E. Fragale
R. Nisha Aurora
Nina A. Cooperman
Daniel D. Langleben
Gary Aston-Jones
机构：
[1] Rutgers University,Brain Health Institute
[2] University of Melbourne,Florey Institute of Neuroscience and Mental Health
[3] Rutgers Robert Wood Johnson Medical School,Department of Medicine
[4] Rutgers Robert Wood Johnson Medical School,Division of Addiction Psychiatry
[5] University of Pennsylvania,Perelman School of Medicine
[6] Philadelphia VA Medical Center,undefined
来源：
Neuropsychopharmacology | 2020年 / 45卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：717 / 719
页数：2
相关论文
共 50 条
  • [31] Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease
    Sun, Hong
    Palcza, John
    Rosenberg, Russell
    Kryger, Meir
    Siringhaus, Tara
    Rowe, Janice
    Lines, Christopher
    Wagner, John A.
    Troyer, Matthew D.
    [J]. RESPIRATORY MEDICINE, 2015, 109 (03) : 416 - 426
  • [32] Repurposing an Opioid Receptor Antagonist as a Treatment for Idiopathic Pulmonary Fibrosis
    Soundararajan, D.
    Madala, S. K.
    Jegga, A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [33] Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative Users
    Landry, Ishani
    Hall, Nancy
    Aluri, Jagadeesh
    Filippov, Gleb
    Reyderman, Larisa
    Setnik, Beatrice
    Henningfield, Jack
    Moline, Margaret
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (04) : 365 - 373
  • [34] Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder
    Dauvilliers, Yves
    Zammit, Gary
    Fietze, Ingo
    Mayleben, David
    Seboek Kinter, Dalma
    Pain, Scott
    Hedner, Jan
    [J]. ANNALS OF NEUROLOGY, 2020, 87 (03) : 347 - 356
  • [35] Antagonist Treatment for Opioid Use Disorder Reply
    Wakeman, Sarah E.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2017, 130 (03): : E119 - E119
  • [36] Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders
    Di Fabio, Romano
    Pellacani, Annalisa
    Faedo, Stefania
    Roth, Adelheid
    Piccoli, Laura
    Gerrard, Philip
    Porter, Rod A.
    Johnson, Christopher N.
    Thewlis, Kevin
    Donati, Daniele
    Stasi, Luigi
    Spada, Simone
    Stemp, Geoffrey
    Nash, David
    Branch, Clive
    Kindon, Leanda
    Massagrande, Mario
    Poffe, Alessandro
    Braggio, Simone
    Chiarparin, Elisabetta
    Marchioro, Carla
    Ratti, Emiliangelo
    Corsi, Mauro
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (18) : 5562 - 5567
  • [37] Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative Users
    Landry, Ishani
    Hall, Nancy
    Alur, Jagadeesh
    Filippov, Gleb
    Reyderman, Larisa
    Setnik, Beatrice
    Henningfield, Jack
    Moline, Margaret
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (04) : 374 - 382
  • [38] SUVOREXANT, A DUAL OREXIN RECEPTOR ANTAGONIST, DOES NOT IMPAIR NEXT DAY DRIVING PERFORMANCE IN HEALTHY ELDERLY SUBJECTS
    Vermeeren, A.
    Vuurman, E.
    Bautmans, A.
    Li, X.
    Vets, E.
    Lewis, N.
    Heirman, I
    Laethem, T.
    Troyer, M.
    Sun, H.
    [J]. SLEEP, 2012, 35 : A226 - A226
  • [39] Translational Studies of AZD4041, a First In-Class Selective Orexin 1 Receptor Antagonist for the Treatment of Opioid Use Disorder
    Nathan, Pradeep
    Kenny, Paul
    Kamenecka, Theodore
    Meno-Tetang, Guy
    Sane, Nandini
    Soleman, Sara
    Davies, Michael
    Hankin, Mark
    Seth, Henrik
    Turner, Andrew
    Rao, Balasubramanya
    Pilling, Mark
    Pouliquen, Isabelle
    Reddy, Venkatesh
    Gebre, Asfiha
    Inamdar, Amir
    Thomson, Fiona
    Ostenfeld, Thor
    Chessell, Iain
    Gurrell, Ian
    [J]. NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 451 - 451
  • [40] Discovery of a novel and potent dual orexin 1/orexin 2 receptor antagonist, E2006, for the treatment of sleep disorders
    Terauchi, Taro
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
12345